Articles

QuickVault Launches New Regulatory Submission Functionality

Regulatory

QuickVault Launches New Regulatory Submission Functionality, Empowering MedTech Companies to Navigate Compliance and Accelerate Growth

QuickVault, a leading device-to-market platform designed to help small and startup MedTech companies achieve commercial success, today announced the launch of its innovative regulatory submission functionality. This enhanced functionality is built into QuickVault’s eQMS solution and is designed to help MedTech companies navigate the complex regulatory submission process with ease and speed.

As the exclusive vendor offering both quality and regulatory functionality in one platform, QuickVault serves as a one-stop-shop solution for MedTech companies. The platform streamlines the submission process, helping companies avoid common pitfalls that can lead to delays, errors, or missed opportunities. The new regulatory functionality allows MedTech companies to automate key workflows to efficiently manage regulatory documentation and submissions, while maintaining compliance with the latest regulations. 

QuickVault’s enhanced regulatory submission functionality include:

  • Streamlined workflows: Simplify and automate regulatory submissions, saving valuable time and reducing manual errors.
  • Enhanced compliance: Ensure adherence to the latest industry regulations and standards, providing peace of mind throughout the submission process.
  • Faster time-to-market: Allow MedTech teams to accelerate product development cycles and launch products more efficiently.
  • Seamless integration: Seamlessly integrate into existing eQMS workflows, supporting businesses at every stage of their journey, from concept to commercialization.

“Veeva MedTech is committed to being the best partner we can be for the MedTech industry. With 80% of MedTech companies having fewer than 50 employees, this segment plays a crucial role in accelerating innovation. Unfortunately, it has been significantly underserved, with quality and regulatory vendors often working in silos” said Seth Goldenberg, President of Veeva MedTech. “QuickVault is the first solution designed specifically for small MedTech companies, where it’s not uncommon for a single engineer to be responsible for everything—from design to creating design files, to regulatory submission, and ultimately, production. We’re excited about the simplification that QuickVault will bring, empowering the innovators driving the MedTech industry forward.”

The introduction of the regulatory submission functionality further strengthens QuickVault’s commitment to supporting the growth of small and startup MedTech companies. As the MedTech industry continues to evolve, QuickVault remains dedicated to providing innovative solutions that help companies thrive in an increasingly complex regulatory environment.

 

To learn more about QuickVault’s new regulatory submission functionality and book a demo, click here.

About QuickVault by Veeva

QuickVault by Veeva accelerates product development, streamlines quality, and simplifies compliance, empowering MedTech companies from concept to commercialization and beyond. By unifying design, submission, and production in a seamless, scalable platform, QuickVault eliminates inefficiencies, ensures continuous compliance, and helps teams stay agile at every stage. With built-in best practices, no implementation costs, and flexible subscription options, QuickVault is ready to grow with you from day one.